Search
Search Results
##search.searchResults.foundPlural##
-
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3265PDF: 2255HTML: 23311Untitled: 200Untitled: 211Untitled: 226 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3155PDF: 1417HTML: 5838Fig1-Ag-Pil: 218Ag-Pil Fig.2: 221 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8988PDF: 6029HTML: 87929Fig.1b: 178Fig.1c: 180Fig.2a: 171Fig.2b: 170Fig.4: 183Fig.2c: 179Fig.3: 177Tab.1: 222Tab.2: 202Tab.3: 184Tab.4: 217Fig1a: 175 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1665PDF: 749HTML: 481 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1343HTML: 382PDF: 810 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1506PDF: 384HTML: 200 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1752PDF: 960HTML: 134 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4751PDF: 1782HTML: 2119 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3508PDF: 2387HTML: 1445 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1100PDF: 480HTML: 223 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3216PDF: 1065HTML: 425 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1164PDF: 744HTML: 1338Figure 1: 182Figure 2: 186 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1166PDF: 487HTML: 208 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1223PDF: 853HTML: 1107Coverletter: 189 -
Anemia in the elderly: not always what it seems.
3277PDF: 1015HTML: 1765Figure 1: 170Figure 1 revised: 173 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1208PDF: 968HTML: 197 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1745PDF: 687HTML: 325 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3491PDF: 1169HTML: 4990Incidence age-standardized rates for HL across the Mediterranean basin: 196 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12309PDF: 1665HTML: 4153Cover letter: 193Figure 1: 199 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1432PDF: 902HTML: 2202Response to reviewers comments: 175 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2059PDF: 1653HTML: 360 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1617PDF: 1164HTML: 191 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1808HTML: 1416PDF: 1066 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2889PDF: 871HTML: 1571 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3283PDF: 1228HTML: 2189 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
927PDF: 572HTML: 328 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1539PDF: 766HTML: 1292







